{
    "clinical_study": {
        "@rank": "36968", 
        "arm_group": [
            {
                "arm_group_label": "Group A: Secondary prevention patients- device implant", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients who are guideline indicated for an ICD/CRT-D for secondary prevention of sudden cardiac arrest.\nThese subjects receive an ICD/CRT-D implant."
            }, 
            {
                "arm_group_label": "Group B: Secondary prevention patients - no device implant", 
                "arm_group_type": "No Intervention", 
                "description": "Patients who are guideline indicated for an ICD/CRT-D for secondary prevention of sudden cardiac arrest.\nThese subjects choose not to receive an ICD/CRT-D implant."
            }, 
            {
                "arm_group_label": "Group C: 1.5 Prevention patients - device implant", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients who are guideline indicated for an ICD/CRT-D for primary prevention of sudden cardiac arrest fall into this group if they have one of the 4 additional risk factors (syncope/pre-syncope, non-sustained ventricular tachycardia (NSVT), frequent preventricular contractions (PVCs), or low left ventricular ejection fraction (low LVEF).\nThese subjects receive an ICD/CRT-D implant."
            }, 
            {
                "arm_group_label": "Group D: 1.5 prevention patients - no device implant", 
                "arm_group_type": "No Intervention", 
                "description": "Patients who are guideline indicated for an ICD/CRT-D for primary prevention of sudden cardiac arrest fall into this group if they have one of the 4 additional risk factors (syncope/pre-syncope, non-sustained ventricular tachycardia (NSVT), frequent preventricular contractions (PVCs), or low left ventricular ejection fraction (low LVEF).\nThese subjects choose not to receive an ICD/CRT-D implant."
            }, 
            {
                "arm_group_label": "Group E: Primary, non-1.5 patients - device implant", 
                "arm_group_type": "Other", 
                "description": "Patients who are guideline indicated for an ICD/CRT-D for primary prevention of sudden cardiac arrest fall into this group if they do NOT fall into the 1.5 prevention group. These patients do not have one of the 4 additional risk factors (syncope/pre-syncope, non-sustained ventricular tachycardia (NSVT), frequent preventricular contractions (PVCs), or low left ventricular ejection fraction (low LVEF) which would put them into the 1.5 prevention group.\nThese subjects receive an ICD/CRT-D implant."
            }, 
            {
                "arm_group_label": "Group F: Primary, non-1.5 patients - no device", 
                "arm_group_type": "No Intervention", 
                "description": "Patients who are guideline indicated for an ICD/CRT-D for primary prevention of sudden cardiac arrest fall into this group if they do NOT fall into the 1.5 prevention group. These patients do not have one of the 4 additional risk factors (syncope/pre-syncope, non-sustained ventricular tachycardia (NSVT), frequent preventricular contractions (PVCs), or low left ventricular ejection fraction (low LVEF) which would put them into the 1.5 prevention group.\nThese subjects choose not to receive an ICD/CRT-D implant."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to demonstrate that primary prevention patients with one or\n      more additional risk factors (1.5 prevention criteria: syncope/pre-syncope, non-sustained\n      ventricular tachycardia (NSVT), frequent pre-ventricular contractions (PVCs), and low left\n      ventricular ejection fraction (LVEF)) are at a similar risk of life-threatening ventricular\n      arrhythmias (LTVA) when compared to secondary prevention patients, and would receive similar\n      benefit from an implantable cardioverter defibrillator (ICD), or cardiac resynchronization\n      therapy- defibrillator (CRT-D) implant."
        }, 
        "brief_title": "Improve Sudden Cardiac Arrest Study", 
        "completion_date": {
            "#text": "April 2018", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Sudden Cardiac Arrest", 
            "Ventricular Arrythmia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Arrhythmias, Cardiac", 
                "Heart Arrest", 
                "Death, Sudden, Cardiac"
            ]
        }, 
        "detailed_description": {
            "textblock": "Devices allowed in the study include any Medtronic single, dual, or triple chamber\n      defibrillator that has received appropriate license or regulatory approval and is\n      commercially available by Medtronic in the geography in which the implant will take place.\n      Any market-released, commercially available lead(s) can be used in the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject has a Class I indication for implantation of an ICD according to the\n             ACC/AHA/HRS or ESC Guidelines\n\n          -  Subject (or subject's legally authorized representative) is willing and able to sign\n             and date the Patient Informed Consent Form.\n\n        Exclusion Criteria:\n\n          -  Subject is \u2264 18 years of age\n\n          -  Subject with any exclusion criteria as required by local law (e.g., age, pregnancy,\n             breast feeding)\n\n          -  Subject is enrolled in a concurrent study that has not been approved for concurrent\n             enrollment by the Medtronic Clinical Trial Leader\n\n          -  Subject has any contraindication for ICD/CRT-D"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "4800", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 26, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02099721", 
            "org_study_id": "Improve SCA"
        }, 
        "intervention": {
            "arm_group_label": [
                "Group A: Secondary prevention patients- device implant", 
                "Group C: 1.5 Prevention patients - device implant", 
                "Group E: Primary, non-1.5 patients - device implant"
            ], 
            "description": "Subjects who receive an ICD/CRT-D device implant will be implanted and follow protocol-specified programming. The programming is not investigational. Consistent programming is desirable in order to compare groups during statistical analysis.", 
            "intervention_name": "ICD or CRT-D Device", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Sudden Cardiac Arrest (SCA)", 
            "Syncope", 
            "NSVT", 
            "PVC", 
            "LVEF", 
            "Primary Prevention", 
            "Secondary Prevention", 
            "ATP", 
            "shock", 
            "appropriate therapy"
        ], 
        "lastchanged_date": "April 17, 2014", 
        "location": [
            {
                "contact": {
                    "email": "zsfuwai@vip.163.com", 
                    "last_name": "Shu Zhang", 
                    "phone": "(861) 088-3988 x33"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Fuwai Hospital Chinese Academy of Medical Sciences and Peking Union Medical College"
                }, 
                "investigator": {
                    "last_name": "Shu Zhang", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "huangdjmd@163.com", 
                    "last_name": "Dejia Huang"
                }, 
                "facility": {
                    "address": {
                        "city": "Sichuan", 
                        "country": "China"
                    }, 
                    "name": "West China Hospital, Sichuan University"
                }, 
                "investigator": {
                    "last_name": "Dejia Huang", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "imran@um.edu.my", 
                    "last_name": "Imran Zainal Abidin", 
                    "phone": "(603) 796-0062 x9"
                }, 
                "facility": {
                    "address": {
                        "city": "Kuala Lumpur", 
                        "country": "Malaysia"
                    }, 
                    "name": "Universiti Malaya Medical Centre"
                }, 
                "investigator": {
                    "last_name": "Imran Zainal Abidin", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "China", 
                "Malaysia"
            ]
        }, 
        "number_of_arms": "6", 
        "official_title": "Improve Sudden Cardiac Arrest Study", 
        "overall_official": {
            "affiliation": "Fuwai Hospital Chinese Academy of Medical Sciences and Peking Union Medical College", 
            "last_name": "Shu Zhang", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Malaysia: Medical Ethics Committee", 
                "China: Medical Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Time to the first occurrence of an episode of true ventricular tachyarrhythmia (VT) or ventricular fibrillation (VF) that is treated by the device (ICD)", 
            "measure": "Appropriately treated VT/VF episodes", 
            "safety_issue": "No", 
            "time_frame": "Implant or study enrollment to approximately 4 years post-implant/enrollment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02099721"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Time to all-cause mortality", 
            "measure": "Mortality", 
            "safety_issue": "No", 
            "time_frame": "Implant or study enrollment to approximately 4 years post-implant/enrollment"
        }, 
        "source": "Medtronic Cardiac Rhythm Disease Management", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medtronic Cardiac Rhythm Disease Management", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}